Insulin detemir in a twice daily insulin regimen versus a three times daily insulin regimen in the treatment of type 1 diabetes in children: A pilot randomized controlled trial

about

Insulin detemir in a twice daily insulin regimen versus a three times daily insulin regimen in the treatment of type 1 diabetes in children: A pilot randomized controlled trial

Item

http://www.wikidata.org/entity/Q35570360

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Insulin detemir in a twice dai ...... ot randomized controlled trial

@ast

Insulin detemir in a twice dai ...... ot randomized controlled trial

@en

type

Item

label

Insulin detemir in a twice dai ...... ot randomized controlled trial

@ast

Insulin detemir in a twice dai ...... ot randomized controlled trial

@en

prefLabel

Insulin detemir in a twice dai ...... ot randomized controlled trial

@ast

Insulin detemir in a twice dai ...... ot randomized controlled trial

@en

P1476

Insulin detemir in a twice dai ...... ot randomized controlled trial

@en

P2093

Alberto Nettel-Aguirre

http://www.w3.org/2001/XMLSchema#string

Carol Huang

http://www.w3.org/2001/XMLSchema#string

Danièle Pacaud

http://www.w3.org/2001/XMLSchema#string

Josephine Ho

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Improving glycaemic control in children and adolescents: which aspects of therapy really matter?

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a prospective study of 10,682 patients from 271 institutions.

Mixing insulin aspart with detemir does not affect glucose excursion in children with type 1 diabetes.

Comparison of the efficacy and safety of insulin glargine and insulin detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus receiving intensive insulin therapy.

A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.

Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes.

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.

P2888

1687-9856-2011-15

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1687-9856-2011-15

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51783102

http://www.w3.org/2001/XMLSchema#string

P6179

1032576931

http://www.w3.org/2001/XMLSchema#string

P698

22067102

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3223134

http://www.w3.org/2001/XMLSchema#string